Hatem A Abdel-Aziz

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Rheumatoid Arthritis

Molecular Docking

Breast Cancer Cells

Tyrosine Kinase

Top Venues

Molecules (Basel, Switzerland)

Drug development research

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Najla A Alshaye, Mohamed K Elgohary, Mahmoud S Elkotamy, Hatem A Abdel-Aziz
Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives as Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny. Molecules (Basel, Switzerland) 29 (6) (2024)
Najla A Alshaye, Mohamed K Elgohary, Mahmoud S Elkotamy, Hatem A Abdel-Aziz
Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives as Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny. Molecules (Basel, Switzerland) 29 (6) (2024)
Najla A Alshaye, Mohamed K Elgohary, Mahmoud S Elkotamy, Hatem A Abdel-Aziz
Design, Synthesis, and Biological Evaluation of Novel Phenoxy Acetic Acid Derivatives as Selective COX-2 Inhibitors Coupled with Comprehensive Bio-Pharmacological Inquiry, Histopathological Profiling, and Toxicological Scrutiny. Molecules (Basel, Switzerland) 29 (6) (2024)
Manal Abdel Fattah Ezzat, Ghada F Elmasry, Menna M A Abd El-Mageed, Marwa Ahmed Fouad, Hatem A Abdel-Aziz, Safaa I Elewa
Design, synthesis, and biological evaluation of furan-bearing pyrazolo[3,4-b]pyridines as novel inhibitors of CDK2 and P53-MDM2 protein-protein interaction. Drug development research (2023)
Mariam M Fakhry, Amr A Mattar, Marwa Alsulaimany, Ebtesam M Al-Olayan, Sara T Al-Rashood, Hatem A Abdel-Aziz
New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study. Molecules (Basel, Switzerland) 28 (21) (2023)
Manal Abdel Fattah Ezzat, Sara Mohamed Abdelhamid, Marwa Ahmed Fouad, Hatem A Abdel-Aziz, Heba Abdelrasheed Allam
Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Drug development research (2023)
Tarfah Al-Warhi, Ahmed M El Kerdawy, Mohamed Adel Said, Amgad Albohy, Zainab M Elsayed, Nada Aljaeed, Eslam B Elkaeed, Wagdy M Eldehna, Hatem A Abdel-Aziz, Miral A Abdelmoaz
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Drug design, development and therapy 16 (2022)
Tarek A Yousef, Essam Ezzeldin, Hatem A Abdel-Aziz, Mohamed H M Al-Agamy, Gamal A E Mostafa
Charge Transfer Complex of Neostigmine with 2,3-Dichloro-5,6-Dicyano-1,4-Benzoquinone: Synthesis, Spectroscopic Characterization, Antimicrobial Activity, and Theoretical Study. Drug design, development and therapy 14 (2020)